Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

21.51
-0.3800-1.74%
Post-market: 21.860.3500+1.63%19:30 EDT
Volume:1.31M
Turnover:28.42M
Market Cap:2.44B
PE:-8.66
High:22.56
Open:22.15
Low:21.51
Close:21.89
52wk High:30.06
52wk Low:11.25
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.71
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:4.65
PE(LYR):-8.85

Loading ...

Genelux Posts Wider-than-Expected Q2 Loss on Higher R&D Expenses

Reuters
·
Aug 14

Inhibrx Biosciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 14

NuCana Q2 Loss Narrows as Clinical Milestones Remain on Track

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

Immunome Director Isaac Barchas Reports Disposal of Common Shares Worth $2.18 Million

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

Immunome Price Target Raised to $35.00/Share from $31.00 by Wedbush

Dow Jones
·
Aug 13

Evercore ISI Remains a Buy on Immunome (IMNM)

TIPRANKS
·
Aug 12

Immunome, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

TIPRANKS
·
Aug 12

Wedbush Adjusts Price Target on Immunome to $35 From $31, Keeps Outperform Rating

MT Newswires Live
·
Aug 12

Piper Sandler Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Aug 12

Simris Alg Q2 Ebitda Loss Narrows

Reuters
·
Aug 12

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 12

Oncology Firm Immunome's Q2 Net Loss Widens as R&D Costs Rise

Reuters
·
Aug 12

Immunome Q2 EPS $(0.65) Misses $(0.52) Estimate

Benzinga Earnings
·
Aug 12

Immunome Rugi Bersih Q2 FY26 Melebar Ke USD 73,13 Juta; Revenue Tidak Ada

Reuters
·
Aug 12

Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 12